Cannabis Medicine Related News
CBD as an aphrodisiac: Exploring its potential
In this article, Dr. Hemp Me explores whether CBD has aphrodisiac potential and looks at what scientific evidence is available.
The word "aphrodisiac" is interesting...
Towards the legalisation of medical cannabis in France
Following the launch of a medical cannabis trial to examine how the drug could be prescribed and dispensed legally, Lorna Rothery spoke to Benjamin-Alexandre...
Fluence selected as an LED technology partner by a major cannabis cultivator in Portugal
Fluence, a leading provider of LED technology solutions for commercial cannabis, is supporting the widespread expansion of medical cannabis cultivation in Portugal.
Portugal decriminalised personal...
NHS plans to offer licensed cannabis medicine for a rare condition
The NHS has announced that they will prescribe cannabis medicine to patients with a rare, seizure-causing genetic disorder in England.
Around one in every 6,000...
CBD brings new hope for bone marrow transplant patients with GvHD
Following promising clinical trials, Dr Sari Prutchi Sagiv outlines the potential of Talent Biotechs’ cannabidiol (CBD) based therapies to transform the lives of bone...
How medical cannabis could be used to alleviate the opioid addiction crisis
A new study has found that medical cannabis could be used as an alternative to opioids for managing pain amid an opioid addiction crisis....
Driving medical cannabis-based therapies forward with biotech
Lorna Rothery spoke to David Bassa who leads various biotech activities focused on the development of novel cannabis-based solutions.
With an impressive portfolio of entrepreneurial...
Study finds high doses of cannabidiol do not affect driving ability
A new study looks at the effects of cannabidiol on driving and found high doses do not impact driving ability or cognitive skills.
Cannabidiol, also...
Championing CBD as a proven alternative to steroid treatment
Stero Biotechs’ innovative CBD formulation could offer new hope to patients with chronic inflammatory and autoimmune diseases where steroid treatment is used.
Three recent POC...
Using medical cannabis for cancer reduces painkiller usage
A new study finds that using medicinal cannabis for cancer can reduce pain and the need for opiate painkillers.
A comprehensive assessment of the benefits...
Promising tablet containing CBD reduces pain after shoulder surgery
A new study finds that an oral tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns.
Researchers from the Department...
Medical marijuana use could result in rapid onset cannabis use disorder
Researchers discover that treating health problems with medical marijuana could lead to the development of cannabis use disorder (CUD).
A new study, carried out by...
Epileptic seizure frequency fell by 86% in kids treated with medicinal cannabis
A new study found that epileptic seizure frequency fell by an average of 86% amongst 10 children treated with whole-plant medicinal cannabis.
Whole plant medicinal...
PURE5 introduces the full-body cannabis terpenes
Industry-leading plant extraction and post-processing specialists PURE5 take us on an insightful journey into the world of cannabis terpenes, their vast array of health...
Leafcann edible essential oils range hits the market
Pioneers of the plant-based medicine industry Leafcann has announced that its new edible essential oils range is now available on the pharmaceutical market.
The product...
Cannabis cultivation, tissue culture, and quality control
Cannadabis leverages its years of industry experience to craft proprietary and highly sought-after cannabis cultivation systems.
Headquartered in Humboldt, Saskatchewan, Canada, Cannadabis Medical Inc is...
UK prescription cannabis recalled that ‘may be contaminated with mould’
UK prescription cannabis supplier NOIDECS has recalled two batches of product and has advised patients not to use their prescription medicine after reports of...
Examining the future of Europe’s medical cannabis treatments
Sita Schubert, the General Secretary of the European Medicinal Cannabis Association, discusses the future of medical cannabis treatments in Europe, looking at how they...
UK policy oversight sees farmers waste millions of pounds worth of CBD
A new report co-ordinated by third sector drug policy reform organisation Volteface has today been released, promising a solution to ‘draconian, pointless’ hemp legislation.
The...
Investing in the future of the medical cannabis industry
Akerna CEO Jessica Billingsley speaks with MCN about the future of the medical cannabis industry, regarding technology, finance and cannabis policy.
Jessica Billingsley, who will...